What are Cell and tissue therapy drugs?

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cell and tissue therapy drugs are pharmacologic agents that share a common mechanism. 0 are currently marketed, with 1 more in clinical development.

Cell and tissue therapy

0 marketed 1 in Phase 3

This page covers all Cell and tissue therapy drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

Phase 3 pipeline (1)

NOVOCART 3D · Aesculap Biologics, LLC · Orthopedics / Regenerative Medicine
NOVOCART 3D is an autologous engineered cartilage construct that regenerates damaged articular cartilage by combining patient's own cells with a 3D scaffold.

Patent intelligence

cell and tissue therapy patent landscape — aggregated cliff calendar, attackable patents, originator estates